
Instil Bio, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€10.34K - Gross profit
-€10.34K - SG&A expenses
€31.30M - R&D expenses
€20.00M - EBITDA
-€68.10M - D&A
€1.43M - EBIT
-€67.99M - Interest expenses
€3.88M - EBT
-€72.81M - Tax expenses
-€818.23K - Net income
-€72.81M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€41.72M - Changes in working capital
-€4.92M - Operating cash flow
-€37.32M - Capex
€0.00 - Other investing cash flow
-€9.15M - Net investing cash flow
€33.29M - Total cash dividends paid
€0.00 - Issuance of common stock
€348.07K - Debt repayment
€2.38M - Other financing cash flow
€3.57M - Net financing cash flow
€6.29M - Foreign exchange effects
€128.37K - Net change in cash
€5.81M - Cash at end of period
€6.75M - Free cash flow
-€37.32M
Balance sheet
- Cash and cash equivalents
€6.62M - Cash and short-term investments
€79.11M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€99.56M - Total current assets
€178.67M - Property, plant & equipment
€637.55K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€10.04M - Other non-current assets
€9.65M - Total non-current assets
€20.33M - Total assets
€199.01M - Accounts payable
€450.59K - Short-term debt
€0.00 - Other current liabilities
€11.48M - Total current liabilities
€11.93M - Long-term debt
€5.17K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€73.63M - Total non-current liabilities
€73.63M - Total liabilities
€85.57M - Common stock
€0.00 - Retained earnings
-€607.14M - Other equity
-€693.55K - Total equity
€113.44M - Total liabilities and shareholders' equity
€199.01M
Company information
- Market capitalization
€128.52M - Employees
14 - Enterprise Value
€239.83M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-64.2% Much better than peer group: -101.8% - ROA
-
-36.6% Better than peer group: -53.2% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-29.0% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€5.20M